Randomized controlled trialHuman
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study
Stroke, 2025 Apr. Homberg V, Jianu DC, Stan A and 7 others.
Study type
Randomized controlled trial
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Stroke
Published
2025 Apr
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
HumansFemaleMalePilot ProjectsMiddle AgedAgedIschemic StrokeDouble-Blind MethodSpeech TherapyAmino AcidsNeuroprotective AgentsAphasia, Broca
Other papers on Cerebrolysin
Systematic review / meta-analysis · 2023
Cerebrolysin for acute ischaemic stroke
Systematic review / meta-analysis · 2019Cerebrolysin for vascular dementia
Review · 2024Neuroprotective and neuroregenerative drugs after severe traumatic brain injury : A narrative review from a clinical perspective
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page